Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 2936-2942

  Hayashi, Terumasa ^a   Obi, Yoshitsugu ^a   Kimura, Tomonori ^a   Iio, Ken Ichiro ^b   Sumitsuji, Satoru ^c   Takeda, Yoshihiro ^a   Nagai, Yoshiyuki ^a   Imai, Enyu ^b  

^a Rinku General Medical Center   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Department of Cardiology   (Japan)

Author keywords

Asymptomatic coronary artery stenosis; Cardiac troponin T; Cardiovascular risk stratification; Chronic kidney disease; Myocardial biomarkers

Indexed keywords

TROPONIN T;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SMOKING;

AGED; ANKLE BRACHIAL INDEX; COMORBIDITY; CORONARY STENOSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; ROC CURVE; TROPONIN T; TUNICA INTIMA; TUNICA MEDIA;

EID: 55349139972     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn181     Document Type: Article

References (35)

1. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003; 108: 2154-2169
2. United States Renal Data System. USRDS Annual Data Report. Bethesda, MD: National Institutes of Health, 2000, 581-584
3. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805
4. Ohtake T, Kobayashi S, Moriya H et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol 2005; 16: 1141-1148
5. Joki N, Hase H, Nakamura R et al. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997; 12: 718-723
6. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
7. Zoccali C, Mallamaci F, Benedetto FA et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-1515
8. Takami Y, Horio T, Iwashima Y et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis 2004; 44: 420-428
9. Dierkes J, Domrose U, Westphal S et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000; 102: 1964-1969
10. Goicoechea M, de Vinuesa SG, Gomez-Campdera F et al. Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk. Am J Kidney Dis 2004; 43: 846-853
11. Khan NA, Hemmelgarn BR, Tonelli M et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112: 3088-3096
12. Apple FS, Murakami MM, Pearce LA et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941-2945
13. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 1993; 132: 1961-1970
14. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969
15. deFilippi C, Wasserman S, Rosanio S et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003; 290: 353-359
16. Mahoney FI, Barthel DW. Functional evaluation: the barthel index. Md State Med J 1965; 14: 61-65
17. Iwashima Y, Horio T, Takami Y et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis 2002; 40: 974-982
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
19. Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367
20. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man.: anatomic validation of the method. Circulation 1977; 55: 613-618
21. Hammond IS, Devereux RB, Alderman MH et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7: 639-650
22. Joki N, Hase H, Ishikawa H et al. Coronary artery disease as a definitive risk factor of short-term outcome after starting hemodialysis in diabetic renal failure patients. Clin Nephrol 2001; 55: 109-114
23. Freda B, Tang WH, Van Lente F et al. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 2002; 40: 2065-2071
24. Lowbeer C, Ottosson-Seeberger A, Gustafsson SA et al. Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease. Nephrol Dial Transplant 1999; 14: 1948-1955
25. Mallamaci F, Zoccali C, Parlongo S et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2002; 40: 68-75
26. Kaye D, Pimental D, Prasad S et al. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest 1996; 97: 281-291
27. Rostand SG, Brunzell JD, Cannon RO III et al. Cardiovascular complications in renal failure. J Am Soc Nephrol 1991; 2: 1053-1062
28. Di Carli MF, Janisse J, Grunberger G et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003; 41: 1387-1393
29. Newman AB, Sutton-Tyrrell K, Vogt MT et al. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993; 270: 487-489
30. Newman AB, Shemanski L, Manolio TA et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in Cardiovascular Health Study. The Cardiovascular Health Study Group. Atheroscler Thromb Vasc Biol 1999; 19: 538-545
31. Ono K, Tsuchida A, Kawai H et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am Soc Nephrol 2003; 14: 1591-1598
32. Nieman K, Cademartiri F, Lemos PA et al. Reliable noninvasive coronary angiography with fast submillimeter multislice spiral computed tomography. Circulation 2002; 106: 2051-2054
33. Ropers D, Baum U, Pohle K et al. Detection of coronary artery stenosis with thin-slice multi-detector row spiral computed tomography and multiplanar reconstruction. Circulation 2003; 107: 664-666
34. Calvillo L, Latini R, Kajstura J et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. PNAS 2003; 100: 4802-4806
35. Guz G, Sahinarslan A, Dhondt AWC et al. Elevated cardiac troponin T in hemodialysis patients receiving more intravenous iron sucrose. Renal Failure 2004; 26: 663-672